Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2, p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma

International Journal of Cancer

Volumn 69, Issue 1, 1996, Pages 5-8

  Sun, Xiao Feng ^a   Carstensen, John M ^b   Stål, Olle ^a   Zhang, Hong ^a   Nordenskjöld, Bo ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; PROTEIN P53;

ADENOCARCINOMA; ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE RAS; PRIORITY JOURNAL; PROGNOSIS; SEX;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RAS PROTEINS; RECEPTOR, ERBB-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029989717     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960220)69:1<5::AID-IJC2>3.0.CO;2-8     Document Type: Article

References (22)

1. AL-SHENEBER, I.F., SHIBATA, H.R., SAMPALIS, J. and JOTHY, S., Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer, 71, 1954-4959 (1993).
2. ARMITAGE, P. and BERRY, G., Statistical methods in medical research. Blackwell, Oxford (1987).
3. BARBACID, M., ras genes, Ann. Rev. Biochem., 56, 779-827 (1987).
4. Cox, D.R., Regression models and life tables. J roy. Statist. Soc. B, 34, 187-220 (1972).
5. FLINT, A., GROSSMAN, H.B., LIEBERT, M., LLOYD, R.V. and BROMBERG, J., DNA and PCNA content of renal cell carcinoma and prognosis. Amer. J. clin. Pathol., 103, 14-19 (1995).
6. GASPARINI, G., BORACCHI, P., VERDERIO, P. and BEVILACOUA, P., Cell kinetics in human breast cancer: comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry. Int. J. Cancer, 57, 822-829 (1994).
7. GASPARINI, G., MELI, S., POZZA, F., CAZZAVILLAN, S. and BEVILACQUA, P., PC-10 antibody to proliferating cell nuclear antigen (PCNA) is not related to prognosis in human breast carcinoma. Growth Regul., 2, 145-150 (1992).
8. KAPLAN, E. and MEIER, P., Nonparametric estimation from incomplete observations. J. Amer. Statist. Assoc., 53, 457-481 (1958).
9. KARLSSON, M., BOERYD, B., CARSTENSEN, J., FRÃNLUND, B., GUSTAVSSON, B., KAGEDAL, B., SUN, X-F. AND WINGREN, S. Correlations of Ki-67 and PCNA to DNA ploidy. S-phase fraction and survival in uveal melanoma. Eur. J. Cancer, (1996). (In press).
10. LANE, D.P., Complex complexes in Cambridge. New Biol., 1, 252-253 (1989).
11. LAZARIS, A.C., DAVATRIS, P., NAKOPOULOU, L., THEODOROPOULOS, G.E., KOULLIAS, G. and GOLEMATIS, B.C., Correlation between immunohistochemical expression of proliferating cell nuclear antigen and flow cytometry parameters in colorectal neoplasia. Dis. Colon Rectum, 37, 1083-1089 (1994).
12. LINDEN, M.D., MA, C.K., KUBUS, J., BROWN, R.D. and ZARBO, R.J., Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas. Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry Amer. J. clin. Pathol., 100, 206-212 (1993).
13. MAGUIRE, JR., H.C. and GREENE, M.I., The neu (c-erbB-2) oncogene. Semun. Oncol., 16, 148-155 (1989).
14. MAYER, A., TAKIMOTO, M., FRITZ, E., SCHELLANDER, G., KOFLER, K. and LUDWIG, H., The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer, 71, 2454-2460 (1993).
15. MING, S.-C., Gastric carcinoma. A pathobiological classification. Cancer, 39, 2475-2485 (1977).
16. MORSON, B.C., Colour atlas of gastrointestinal pathology. In: R.C. Curran (ed.), Oxford colour atlases of pathology, Oxford University Press, Oxford (1988).
17. PIGNATELLI, M., STAMP, G.W.H., KAFIRI, G., LANE, D. and BODMER, W.F., Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int. J. Cancer, 50, 683-588 (1992).
18. QUIRKE, P., DIXON, M.F., CLAYDEN, A.D., DURDEY, P., DYSON, J.E.D., WILLIAMS, N.S. and BIRD, C.C., Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J. Pathol., 151, 285-291 (1987).
19. TEIXEIRA, C.R., TANAKA, S., HARUMA, K., YOSHIHARA, M., SUMII, K. and KAJIYAMA, G., Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer, 73, 575-579 (1994).
20. THOMAS, M., NOGUCHI, M., KITAGAWA, H., KINOSHITA, K. and MIYAZAKI, I., Poor prognosis value of proliferating-cell-nuclearantigen labelling index in breast carcinoma. J. clin. Pathol., 46, 525-528 (1993).
21. VISAKORPI, T., Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. J. Pathol., 168, 7-13 (1992).
22. WILLETT, C.G., WARLAND, G., CHEEK, R., COEN, J., EFIRD, J., SHELLITO, P.C. and COMPTON, C.C., Proliferating cell nuclear antigen and mitotic activity in rectal cancer: predictor of response to preoperative irradiation. J. clin. Oncol., 12, 679-682 (1994).